Stockchase Opinions

Jim Cramer - Mad Money IDEXX Laboratories IDXX-Q HOLD Nov 11, 2020

They offer healthcare to animals and pets. Stay with it. He believes in how they serve pets.
$455.060

Stock price when the opinion was issued

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
These lab stocks are news-driven and could drop on a negative headline. Each time it pulled back, it bounced back higher. The chart looks good here and he would buy.
DON'T BUY
Jan.6-April 27 is seasonality. Healthcare stocks have made huge gains, but not IDXX. It's rolling over now and resisting its 200-day moving average. He's concerned. It's underperforming.
WEAK BUY

Makes diagnostic equipment for veterinarians. It has sold off hard, because pet plays are seen as Covid stocks, but has been recovering (reported a beat in early August), but shares have been cold since that report.

DON'T BUY

They're too inconsistent.

BUY

Is up 26% today. He expects it to top $706.

BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

IDXX recently reported solid numbers as its topline growth accelerated to around 15% compared to previous quarters of around mid-to-high single digits. The company reacted favourably to the news as its share price jumped more than 20% in a single day. We think IDXX’s investment thesis as a high-quality, capital-light compounder in the pet healthcare industry remains intact. That being said, IDXX is now trading at around 50x Forward P/E, and growth over the next few years is expected to be around 8%-9%. We are comfortable holding the position here, but we don’t think it is too attractive to add at the current levels. We would prefer to be patient and wait for another opportunity to add to the name.
Unlock Premium - Try 5i Free